Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Masimo Corporation is a medical instruments & supplies business based in the US. Masimo Corporation shares (MASI) are listed on the NASDAQ and all prices are listed in US Dollars. Masimo Corporation employs 4,000 staff and has a trailing 12-month revenue of around $2 billion.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $173.57 |
|---|---|
| 52-week range | $108.89 - $184.97 |
| 50-day moving average | $169.37 |
| 200-day moving average | $148.21 |
| Wall St. target price | $188.13 |
| PE ratio | 65.221 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $2.67 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $173.57 from 2023-03-27
| 1 week (2023-03-21) | -1.73% |
|---|---|
| 1 month (2023-02-28) | 3.74% |
| 3 months (2022-12-28) | 19.70% |
| 6 months (2022-09-28) | 20.26% |
| 1 year (2022-03-28) | 11.96% |
|---|---|
| 2 years (2021-03-26) | -24.36% |
| 3 years (2020-03-27) | 179.03 |
| 5 years (2018-03-28) | 102.23% |
Valuing Masimo Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Masimo Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $2 billion |
|---|---|
| Operating margin TTM | 11.13% |
| Gross profit TTM | $1.1 billion |
| Return on assets TTM | 5.56% |
| Return on equity TTM | 9.93% |
| Profit margin | 7.05% |
| Book value | $25.50 |
| Market capitalisation | $9.2 billion |
TTM: trailing 12 months
We're not expecting Masimo Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Masimo Corporation's shares have ranged in value from as little as $108.89 up to $184.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Masimo Corporation's is 0.8558. This would suggest that Masimo Corporation's shares are less volatile than average (for this exchange).
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and O3 regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth. com, amazon. com, and shopify. com.
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.